Latest News and Press Releases
Want to stay updated on the latest news?
-
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment...
-
RICHMOND, Va., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Xenith Bankshares, Inc. (formerly known as Hampton Roads Bankshares, Inc.) (NASDAQ:XBKS), parent company of Xenith Bank (formerly known as The Bank...
-
MCLEAN, Va., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Gladstone Capital Corporation (NASDAQ:GLAD) (“Gladstone Capital”) announced that it has completed a $10 million 2nd lien debt investment in Merlin...
-
REDWOOD CITY, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Dextera Surgical Inc. (Nasdaq:DXTR) today announced financial results for its fiscal fourth quarter and full year ended June 30, 2016. The...
-
Ventricular tachycardia procedures increased 24% year over year, representing the 10th consecutive quarter of year-over-year volume growthThree Niobe® system installations completed, including the...
-
Net income reaches $2.2 million; revenues of $16.0 million include milestone payments from GSK and a major biopharmaceutical company, and 62% growth in core biocatalyst product sales Conference...
-
PHOENIX, Aug. 09, 2016 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (NASDAQ:CVCO) today announced financial results for the first fiscal quarter ended July 2, 2016. Financial highlights include...
-
VANCOUVER, British Columbia, Aug. 09, 2016 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) (“QLT” or the “Company”) reported financial results today for the second quarter ended June 30, 2016....
-
MENLO PARK, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a gene therapy company committed to discovering and developing novel medicines for patients...
-
KIRKLAND, Wash., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Rightside Group, Ltd. (Nasdaq:NAME), a leading provider of domain name services that advance the way businesses and consumers define and present...